Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc2b03342511abc88f60c63f2acd96d0 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-10001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-179 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
filingDate |
2011-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8a6437fcb8c97a28e7f0e2f58c86907 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_368bdd0a64216a2002b6630d7018feef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50676f21a54759828e788aacb5a99d42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a15a323f274e48559de4e197bd81b47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fcef86930615829b37a453cf2dafa25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87f5783993633341964259ed1c4e6ad8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d290fa4643d2a2cdcd36e4071b1efc27 |
publicationDate |
2016-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2011207381-B2 |
titleOfInvention |
Inhibition of AXL signaling in anti-metastatic therapy |
abstract |
Compositions and methods are provided for alleviating cancer in a mammal by administering a therapeutic dose of a pharmaceutical composition that inhibits activity of AXL protein activity, for example by competitive or non-competitive inhibition of the binding interaction between AXL and its ligand GAS6. |
priorityDate |
2010-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |